Liquidia LQDA
NASDAQ LQDA
$28.64 +0.65 (+2.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Liquidia (LQDA) Gains from Sales and Divestitures (2021 - 2024)

Updated

Liquidia (LQDA) posted Gains from Sales and Divestitures of -$11,000 for FY2025, compared with -$46,000 in FY2024.

Analysis

Liquidia (LQDA) Gains from Sales and Divestitures (2021 - 2024) Analysis & Trends

Since FY2019, Liquidia has reported Gains from Sales and Divestitures for 7 years.

  • Annual Gains from Sales and Divestitures has run from a low of -$46,000 in FY2024 to a high of $2,000 in FY2023 over five years.
  • Business Quant data shows LQDA's Gains from Sales and Divestitures at -$46,000 in FY2024, $2,000 in FY2023, -$4,000 in FY2022 and -$44,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Liquidia 2.55 Bn 1.70 Bn 160.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -43,000.00
Mar 31, 2024 -3,000.00
Mar 31, 2023 2,000.00
Dec 31, 2022 -3,000.00
Dec 31, 2021 -15,000.00
API Access

Liquidia Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=LQDA&period=max&api_key=YOUR_API_KEY